Escalier Biosciences Scores $19 Million in Funding Supporting Therapies for Psoriasis and Other Autoimmune Diseases

Escalier Biosciences and its dermatologic and autoimmune targets received a $19 million series B round funding from European Venture Capital firms Forbion, New Science Ventures and BioGeneration. 

“Escalier’s team has an impressive track record of developing novel compounds targeting diseases with significant unmet medical need,” stated Marco Boorsma, general partner at Forbion who will join Escalier’s board for financing. “We are excited to participate in this financing with New Science Ventures and BioGeneration Ventures and in supporting Escalier’s efforts to develop best-in-class drugs for the treatment of psoriasis and other autoimmune diseases.” 

The nuclear hormone receptor RORγt has emerged as the master regulator of Th17 cell differentiation and the production of pro-inflammatory cytokines. The funding will be used to create small molecule inhibitors of RORγt to lower the production of IL-17 in immune cells. Escalier is also developing both topical and oral RORγt drug candidates for psoriasis, and looks to begin clinicals with its topical compound in 2018.[1] 

“RORγt is a validated target for psoriasis and other autoimmune disorders and our drug candidates have the potential to provide the desired efficacy and safety in psoriasis patients that is currently unavailable with other topical or oral drugs,” said Raju Mohan, Ph.D., Chief Executive Officer of Escalier. “We are incredibly fortunate to have such a supportive syndicate of investors that share our passion in developing novel therapies for challenging targets such as RORγt.”

[1]https://www.prnewswire.com/news-releases/escalier-biosciences-raises-19-million-to-develop-its-topical-and-systemic-rort-therapies-for-psoriasis-and-other-autoimmune-diseases-300613033.html

Latest

Beyond the Classroom: Educational Reform in a Post-Pandemic World
April 22, 2021
Although no one can argue that the COVID-19 pandemic has set back education and student learning for months, if not years, there is still some good that has come out of our current situation. Now, educators Read more
How Telehealth Will Shape K12 Health Services In 2021
April 22, 2021
 Telehealth services grew out of necessity during the COVID-19 pandemic, but they’re here to stay. The rapid acceleration of telehealth also forces those in EdTech to incorporate telehealth services to students, Read more
‘Mr. Supply Chain’ on Careers in an Evolving Logistics Landscape
April 22, 2021
Supply chains have been a hot topic of conversation since the COVID-19 pandemic began, as the ensuing chaos ground many of them across the world to a screeching halt. Now, however, with a new normal coming to life Read more